- This event has passed.
Riyadh
Jul 16 • 10:09 PM
Kalshi Launches Sportsbook-Style Markets on Drug Trials and FDA Decisions
Elie G. Dib: How Long Does Maintenance Therapy Actually Need to Last?
Sacituzumab Tirumotecan Plus Pembrolizumab Meets Phase III Endpoint in First-Line PD-L1-Negative Non-Squamous NSCLC
Asparaginase Drug Monitoring in Pediatric ALL: The Brazilian Experience - Resonance
Hope for Stomach Cancer and OncoDaily Announce Strategic Media Partnership
TOPAZ-1 Post Hoc Analysis: Durvalumab Plus GemCis in Advanced Biliary Tract Cancer
Four-Arc Coplanar VMAT Emerges as a Practical Option for Hippocampal-Sparing Whole-Brain Radiotherapy
KEYNOTE-C93: Pembrolizumab May Replace Chemotherapy in dMMR Endometrial Cancer
